We developed an attachment device that permits use of the US Food and Drug Administration–approved Optovue AngioVue to obtain OCTA images of recumbent patients under general anesthesia. Although there is currently technology that allows for OCT imaging of recumbent patients under anesthesia, there is no US Food and Drug Administration–approved method of obtaining OCTA images of such patients, which prompted development of our prototype device. In its current state, adult faces will not fit under the eye piece. To fix this, the angle of the mirror should be decreased and the patient's head should be rotated slightly to one side using a neck rest to stabilize the head. To solve the vignetting, the optical path may have to be shortened, which may be possible if the angle of the mirror is decreased. Another solution to extending the working distance of the machine is a relay lens; however, this strategy would add complexity to the design and increase the cost. This relay lens solution should be explored if the simpler solution of changing the angle of the mirror and shortening the optical path does not solve the vignetting issues and does not accommodate adult heads. Regardless of the imaging limitations, this device could be valuable for the long-term monitoring of patients, because imaging artifacts may remain stable for a given patient, allowing for adequate comparison of images over time.
This device has proven to produce good quality OCTA imaging of patients sedated in a recumbent position. It enables imaging of patients who otherwise would not be able to be imaged and expands OCTA potential in retinal diagnoses.